Thermo Fisher Scientific Inc (TMO) Shares Bought by Wesbanco Bank Inc.

Wesbanco Bank Inc. boosted its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 0.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,998 shares of the medical research company’s stock after acquiring an additional 429 shares during the quarter. Wesbanco Bank Inc.’s holdings in Thermo Fisher Scientific were worth $8,549,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Whalerock Point Partners LLC grew its holdings in Thermo Fisher Scientific by 2.4% during the 2nd quarter. Whalerock Point Partners LLC now owns 2,866 shares of the medical research company’s stock worth $500,000 after acquiring an additional 66 shares during the last quarter. Principal Financial Group Inc. grew its holdings in Thermo Fisher Scientific by 43.8% during the 2nd quarter. Principal Financial Group Inc. now owns 806,616 shares of the medical research company’s stock worth $140,730,000 after acquiring an additional 245,662 shares during the last quarter. Motco grew its holdings in Thermo Fisher Scientific by 0.5% during the 2nd quarter. Motco now owns 33,313 shares of the medical research company’s stock worth $5,812,000 after acquiring an additional 163 shares during the last quarter. Homrich & Berg grew its holdings in Thermo Fisher Scientific by 12.1% during the 2nd quarter. Homrich & Berg now owns 2,139 shares of the medical research company’s stock worth $373,000 after acquiring an additional 231 shares during the last quarter. Finally, Veritas Asset Management LLP grew its holdings in Thermo Fisher Scientific by 112.4% during the 2nd quarter. Veritas Asset Management LLP now owns 2,430,759 shares of the medical research company’s stock worth $424,095,000 after acquiring an additional 1,286,259 shares during the last quarter. 83.36% of the stock is currently owned by hedge funds and other institutional investors.

Thermo Fisher Scientific Inc (NYSE:TMO) opened at 193.21 on Friday. The company has a market cap of $75.37 billion, a price-to-earnings ratio of 33.66 and a beta of 1.05. Thermo Fisher Scientific Inc has a 52 week low of $139.07 and a 52 week high of $194.30. The stock has a 50 day moving average of $186.68 and a 200 day moving average of $173.88.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter in the prior year, the firm posted $2.03 earnings per share. The firm’s revenue was up 10.2% compared to the same quarter last year. Equities research analysts predict that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.31%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.45%.

TMO has been the topic of a number of research analyst reports. Cowen and Company reissued an “outperform” rating and set a $220.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Goldman Sachs Group, Inc. (The) initiated coverage on shares of Thermo Fisher Scientific in a report on Tuesday, September 26th. They set a “buy” rating and a $225.00 price objective on the stock. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Tuesday, September 12th. Citigroup Inc. reissued a “buy” rating and set a $201.00 price objective (up previously from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. Finally, BidaskClub raised shares of Thermo Fisher Scientific from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 11th. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Thermo Fisher Scientific has a consensus rating of “Buy” and a consensus price target of $202.21.

ILLEGAL ACTIVITY WARNING: This article was first published by Transcript Daily and is owned by of Transcript Daily. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://transcriptdaily.com/2017/10/08/thermo-fisher-scientific-inc-tmo-shares-bought-by-wesbanco-bank-inc.html.

In related news, VP Seth H. Hoogasian sold 4,140 shares of the company’s stock in a transaction that occurred on Monday, August 28th. The stock was sold at an average price of $177.80, for a total value of $736,092.00. Following the sale, the vice president now directly owns 25,518 shares in the company, valued at $4,537,100.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director C Martin Harris sold 360 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the sale, the director now owns 5,312 shares in the company, valued at $961,312.64. The disclosure for this sale can be found here. Insiders sold 52,738 shares of company stock valued at $9,302,112 in the last ninety days. 0.49% of the stock is currently owned by insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply